Clinical Trials in Sylmar, California
6 recruiting
Showing 1–6 of 6 trials
Recruiting
Phase 3
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Endometrial Cancer
AstraZeneca600 enrolled249 locationsNCT06989112
Recruiting
Phase 3
Mirvetuximab Soravtansine With Bevacizumab Versus Bevacizumab as Maintenance in Platinum-sensitive Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer
Ovarian CancerFallopian Tube CancerPeritoneal Cancer
AbbVie520 enrolled264 locationsNCT05445778
Recruiting
Phase 2
Low PSMA SUV Boost (LPS-Boost): Intensified 177Lu-PSMA-617 Treatment for Patients With Metastatic Castrate-Resistant Prostate Cancer With Low PSMA Expressing Disease
Stage IVB Prostate Cancer AJCC v8Metastatic Castration-Resistant Prostate Carcinoma
University of Washington51 enrolled3 locationsNCT06526299
Recruiting
Not Applicable
Starting Technology in At Risk Type 1 Diabetes Study
Diabetes Mellitus, Type 1
University of California, Los Angeles40 enrolled3 locationsNCT06453928
Recruiting
Not Applicable
Reducing Blood Pressure in Patients With High Cardiovascular Risk
HypertensionStrokeMyocardial Infarction
University of Southern California546 enrolled4 locationsNCT05937685
Recruiting
Decellularized Femoral Artery Allograft (Nexeon AVX) Prospective Registry
End Stage Renal Disease
LifeNet Health100 enrolled4 locationsNCT05880537